Register entry

LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
0
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human otc drug. By marketing category: OTC MONOGRAPH DRUG 2.

Dosage formNDCs
cream1
stick1
RouteNDCs
topical2
Labeller name on the listingNDCs
lundquist institute for biomedical innovation at harbor-ucla medical center2
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
Mineral Lip SunscreenTitanium Dioxide, Zinc Oxidestick, topical85625-212OTC MONOGRAPH DRUG
Non Tinted Replenishing Daily ProtectionZinc Oxidecream, topical85625-226OTC MONOGRAPH DRUG
Compare

Other companies listing titanium dioxide, zinc oxide

Enquiry

Common questions

Is LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER FDA approved?
LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER make?
2 products are listed under LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER in the openFDA NDC Directory, most often as cream; stick. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.